3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
24
Breast Neoplasms
22
Multiple Myeloma
11
Neoplasm Metastasis
9
Pain
8
Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Bone Neoplasms
5
Osteoporosis
4
Fractures, Bone
4
Bone Diseases
4
Lung Neoplasms
3
Bone Diseases, Metabolic
3
Spinal Cord Compression
2
Humoral Hypercalcemia Of Malignancy
2
Treatment of Bone Metastases
1
Small Cell Lung Carcinoma
1
Renal Insufficiency
1
Pleural Effusion, Malignant
1
Paraproteinemias
1
Neoplastic Processes
1
Neoplastic Cells, Circulating
1
Neoplasms, Plasma Cell
1
Neoplasm, Residual
1
Lymphoma
1
Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Disease Progression
1
Carcinoma, Renal Cell
1
Interventions
Blood Specimen Collection
4
Zoledronic Acid
1
Standard of Care
1
Diphosphonates
1
Data Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Neoplastic Cells, Circulating
×
Zoledronic Acid
×
Clear all
NCT01129336
2014-05-20
MACS1295
Novartis
Phase 4
Completed
44 enrolled
10 charts